DE4313620A1 - Hamsterzellinien und Verfahren zur Glykoproteingewinnung - Google Patents

Hamsterzellinien und Verfahren zur Glykoproteingewinnung

Info

Publication number
DE4313620A1
DE4313620A1 DE4313620A DE4313620A DE4313620A1 DE 4313620 A1 DE4313620 A1 DE 4313620A1 DE 4313620 A DE4313620 A DE 4313620A DE 4313620 A DE4313620 A DE 4313620A DE 4313620 A1 DE4313620 A1 DE 4313620A1
Authority
DE
Germany
Prior art keywords
cell line
glycoprotein
cells
hamster
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE4313620A
Other languages
German (de)
English (en)
Inventor
Hans Prof Dr Dr Wolf
Klaus Dr Scharfenberg
Roland Dr Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WOLF, HANS, PROF. DR., 93053 REGENSBURG, DE
Original Assignee
GESELLSCHAFT fur BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) 38124 BRAUNSCHWEIG DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GESELLSCHAFT fur BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) 38124 BRAUNSCHWEIG DE filed Critical GESELLSCHAFT fur BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) 38124 BRAUNSCHWEIG DE
Priority to DE4313620A priority Critical patent/DE4313620A1/de
Priority to CN94192251A priority patent/CN1124502A/zh
Priority to EP94915547A priority patent/EP0695357A1/de
Priority to KR1019950704749A priority patent/KR100255228B1/ko
Priority to NZ266146A priority patent/NZ266146A/en
Priority to CA002161517A priority patent/CA2161517A1/en
Priority to PCT/EP1994/001318 priority patent/WO1994025599A1/de
Priority to AU67220/94A priority patent/AU6722094A/en
Priority to JP6523875A priority patent/JPH08509369A/ja
Publication of DE4313620A1 publication Critical patent/DE4313620A1/de
Priority to AU78958/98A priority patent/AU7895898A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE4313620A 1993-04-26 1993-04-26 Hamsterzellinien und Verfahren zur Glykoproteingewinnung Ceased DE4313620A1 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE4313620A DE4313620A1 (de) 1993-04-26 1993-04-26 Hamsterzellinien und Verfahren zur Glykoproteingewinnung
CA002161517A CA2161517A1 (en) 1993-04-26 1994-04-26 Mammalian cell lines and method of obtaining glycoproteins
EP94915547A EP0695357A1 (de) 1993-04-26 1994-04-26 Säugerzellinien und verfahren zur glykoproteingewinnung
KR1019950704749A KR100255228B1 (ko) 1993-04-26 1994-04-26 글리코프로테인을 발현시키는 포유류 세포계 및 글리코프로테인의 제조 방법
NZ266146A NZ266146A (en) 1993-04-26 1994-04-26 Glycoproteins expressed from mammalian cell lines
CN94192251A CN1124502A (zh) 1993-04-26 1994-04-26 哺乳动物细胞系和获得糖蛋白的方法
PCT/EP1994/001318 WO1994025599A1 (de) 1993-04-26 1994-04-26 Säugerzellinien und verfahren zur glykoproteingewinnung
AU67220/94A AU6722094A (en) 1993-04-26 1994-04-26 Mammal cell lines and method of obtaining glycoproteins
JP6523875A JPH08509369A (ja) 1993-04-26 1994-04-26 哺乳類株化細胞および糖蛋白の生産方法
AU78958/98A AU7895898A (en) 1993-04-26 1998-08-11 Mammal cell lines and method of obtaining glycoproteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4313620A DE4313620A1 (de) 1993-04-26 1993-04-26 Hamsterzellinien und Verfahren zur Glykoproteingewinnung

Publications (1)

Publication Number Publication Date
DE4313620A1 true DE4313620A1 (de) 1994-10-27

Family

ID=6486397

Family Applications (1)

Application Number Title Priority Date Filing Date
DE4313620A Ceased DE4313620A1 (de) 1993-04-26 1993-04-26 Hamsterzellinien und Verfahren zur Glykoproteingewinnung

Country Status (9)

Country Link
EP (1) EP0695357A1 (ja)
JP (1) JPH08509369A (ja)
KR (1) KR100255228B1 (ja)
CN (1) CN1124502A (ja)
AU (1) AU6722094A (ja)
CA (1) CA2161517A1 (ja)
DE (1) DE4313620A1 (ja)
NZ (1) NZ266146A (ja)
WO (1) WO1994025599A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2906683B1 (en) 2012-10-15 2017-05-31 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
JP2003506077A (ja) * 1999-08-05 2003-02-18 バクスター アクチェンゲゼルシャフト 組換え安定細胞クローン、その産生およびその使用
EP2287288B1 (en) 2002-07-09 2012-11-07 Baxter International Inc. Animal protein free media for cultivation of cells
TWI384069B (zh) * 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
EP1974014B1 (en) 2006-01-04 2017-04-19 Baxalta Incorporated Oligopeptide-free cell culture media
JP5995397B2 (ja) * 2009-03-09 2016-09-21 東洋製罐グループホールディングス株式会社 細胞培養方法、及び細胞培養装置
JP2011004754A (ja) * 2010-08-05 2011-01-13 Baxter Ag 組換え安定細胞クローン、その産生およびその使用
JP6097725B2 (ja) * 2014-07-09 2017-03-15 バクスアルタ・イノベイションズ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｘａｌｔａ Ｉｎｎｏｖａｔｉｏｎｓ ＧｍｂＨ 組換え安定細胞クローン、その産生およびその使用
JP6245299B2 (ja) * 2016-04-27 2017-12-13 バクスアルタ ゲーエムベーハー 組換え安定細胞クローン、その産生およびその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO162160C (no) * 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
EP0312164A1 (en) * 1987-10-16 1989-04-19 Merck & Co. Inc. Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
JPH04228066A (ja) * 1990-10-23 1992-08-18 Rikagaku Kenkyusho 外来遺伝子発現用培養細胞

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2906683B1 (en) 2012-10-15 2017-05-31 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production

Also Published As

Publication number Publication date
AU6722094A (en) 1994-11-21
CA2161517A1 (en) 1994-11-10
KR100255228B1 (ko) 2000-05-01
JPH08509369A (ja) 1996-10-08
WO1994025599A1 (de) 1994-11-10
CN1124502A (zh) 1996-06-12
NZ266146A (en) 1997-11-24
EP0695357A1 (de) 1996-02-07

Similar Documents

Publication Publication Date Title
DE69929612T2 (de) Purifikation von viruspräparaten
EP1427817B1 (de) Vermehrung von viren in zellkultur
DE19612966B4 (de) MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE4313620A1 (de) Hamsterzellinien und Verfahren zur Glykoproteingewinnung
DE69626022T3 (de) Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff
DE3227262C2 (ja)
EP2216400A1 (de) Verfahren zur Herstellung eines aktiven Bestandteils eines Arznei- oder Diagnosemittels in MDCK-Zell-Suspensionskultur
EP0011243A1 (de) Verfahren zur Herstellung von Membranproteinen aus Neisseria meningitidis und diese enthaltende Vaccine
CN109069592A (zh) 纯化胶原7的方法
JPH10500286A (ja) ウイルス粒子の効率の高い生産および単離
DE69124235T3 (de) Reinigung und verwendung von pertactin, eines bordetella pertussis aussenmembranproteins
DE3718939C2 (de) Verfahren zur Herstellung von biologisch aktivem Plasminogenaktivator
AT391808B (de) Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
DE2636757A1 (de) Verfahren zum aufkonzentrieren und reinigen des antihaemophiliefaktors
CH615947A5 (en) Process for the cultivation of anchorage-dependent cells in a microcarrier culture, microcarriers for carrying it out and use of the process.
DE2828073C2 (de) Verfahren zum Kultivieren von Viren
EP1149167A2 (de) Virus-vakzine
WO1991009935A1 (de) Matrix mit daran adhärent gebundenen zellen, sowie verfahren zur produktion von virus/virusantigen
DE102004049290A1 (de) Verfahren zur Herstellung von Virusmaterial
AU2014326706A1 (en) Method for the clarification of high density crude cell culture harvest
Matuszewski et al. Gene amplification and its effect on the structure and function of the oocyte nucleus in the whirligig beetle Gyrinus natator (Gyrinidae, Coleoptera-Adephaga)
DE3517656A1 (de) Verfahren zur herstellung von makromolekuelen durch dna-transformation
DE3101001A1 (de) Verfahren zur konzentration und reinigung des antihaemophilie-faktors oder faktor viii
EP2839012B1 (de) Verfahren zur erhöhung der sekretion rekombinanter proteine
EP0321606B1 (de) Zelluläre amphipatische Proteine in aggregierten Formen und Verfahren zur Herstellung und Reinigung diese Proteine

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: WOLF, HANS, PROF. DR., 93053 REGENSBURG, DE

8110 Request for examination paragraph 44
8110 Request for examination paragraph 44
8131 Rejection